Diane Goere
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
Steffen T, Yutaka Y, Paul S, Beate R, Quadros C, Pompiliu P, Morris D, Moran B, Yan L, Ignace d, Goere D, Glehen O, Glatzer M, Lana B, Häller L, Putora P. Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI). Oncology 2020; 99:41-48.
Sep 11, 2020Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
Sep 11, 2020Oncology 2020; 99:41-48
Steffen Thomas, Yutaka Yonemura, Paul Sugarbaker, Beate Rau, Quadros Claudio A, Pompiliu Piso, Morris David L, Moran Brendan J, Yan Li, Ignace de Hingh, Goere Diane, Glehen Olivier, Glatzer Markus, Lana Bijelic, Häller Lukas, Putora Paul Martin
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
Steffen T, Yutaka Y, Paul S, Beate R, Claudio Q, Pompiliu P, David M, Brandon M, Yan L, Ignace d, Goere D, Glehen O, Glatzer M, Lana B, Eden J, Martin P. Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts. Clin Colorectal Cancer 2020; 19:277-284.
Jul 15, 2020Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
Jul 15, 2020Clin Colorectal Cancer 2020; 19:277-284
Steffen Thomas, Yutaka Yonemura, Paul Sugarbaker, Beate Rau, Claudio Quadros, Pompiliu Piso, David Morris, Brandon Moran, Yan Li, Ignace de Hingh, Goere Diane, Glehen Olivier, Glatzer Markus, Lana Bijelic, Eden Janina, Martin Putora Paul
Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization
De Baère T, Elias D, Goere D, Auperin A, Hakime A, Rao P, Catherine L, Deschamps F, Teriitehau C, Hechelhammer L. Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization. Ann Surg Oncol 2010; 17:2081-9.
Mar 17, 2010Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization
Mar 17, 2010Ann Surg Oncol 2010; 17:2081-9
De Baère Thierry, Elias Dominique, Goere Diane, Auperin Anne, Hakime Antoine, Rao Pramod, Catherine Laurence, Deschamps Frédéric, Teriitehau Christophe, Hechelhammer Lukas
Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion
De Baère T, Goere D, Auperin A, Abdel-Rehim M, Hechelhammer L, Boige V, Dromain C, Briggs P, Deschamps F, Elias D. Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion. Radiology 2008; 248:1056-66.
Jul 15, 2008Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion
Jul 15, 2008Radiology 2008; 248:1056-66
De Baère Thierry, Goere Diane, Auperin Anne, Abdel-Rehim Mohamed, Hechelhammer Lukas, Boige Valérie, Dromain Clarisse, Briggs Patricio, Deschamps Frédéric, Elias Dominique